Glial cell line derived neurotrophic factor promotes the recovery of dopamine neurons damaged by 6-hydroxydopamine in vitro

被引:30
作者
Kramer, BC
Goldman, AD
Mytilineou, C
机构
[1] CUNY Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Fishberg Ctr Neurobiol, New York, NY 10029 USA
关键词
glial cell line derived neurotrophic factor; 6-hydroxydopamine; mesencephalic culture; dopamine neuron;
D O I
10.1016/S0006-8993(99)02191-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glial cell line derived neurotrophic factor (GDNF) has been shown to be a potent neurotrophic factor for dopamine neurons in culture and to prevent the loss of substantia nigra dopamine neurons following in vivo lesions with 6-hydroxydopamine (6-OHDA). In this study we used mesencephalic cultures containing both neurons and glia to examine whether GDNF protects dopamine neurons from 6-OHDA toxicity in vitro. Our data show that GDNF does not prevent the loss of dopamine neurons caused by treatment with 6-OHDA in vitro. However, continuous exposure to GDNF increases the high affinity dopamine uptake in cultures treated with 6-OHDA, suggesting that it enhances the growth of damaged dopamine neurons. We also show that in vitro treatment with 6-OHDA causes widespread cell death in mesencephalic cultures, which is not restricted to dopamine neurons. The lack of selectivity of 6-OHDA toxicity when applied in vitro may explain the inability of GDNF to prevent the loss of dopamine neurons in mesencephalic cultures. The stimulation of the growth of 6-OHDA damaged dopamine neurons by GDNF, observed in our study, suggests that it may prove beneficial in the treatment of injured dopamine neurons. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:221 / 227
页数:7
相关论文
共 21 条
[1]   MESENCEPHALIC DOPAMINERGIC-NEURONS PROTECTED BY GDNF FROM AXOTOMY-INDUCED DEGENERATION IN THE ADULT BRAIN [J].
BECK, KD ;
VALVERDE, J ;
ALEXI, T ;
POULSEN, K ;
MOFFAT, B ;
VANDLEN, RA ;
ROSENTHAL, A ;
HEFTI, F .
NATURE, 1995, 373 (6512) :339-341
[2]  
Clarkson ED, 1995, NEUROREPORT, V7, P145, DOI 10.1097/00001756-199512290-00035
[3]  
COHEN G, 1974, J BIOL CHEM, V249, P2447
[4]  
DECKER DE, 1993, RES COMMUN CHEM PATH, V79, P195
[5]   Functional recovery in parkinsonian monkeys treated with GDNF [J].
Gash, DM ;
Zhang, ZM ;
Ovadia, A ;
Cass, WA ;
Yi, A ;
Simmerman, L ;
Russell, D ;
Martin, D ;
Lapchak, PA ;
Collins, F ;
Hoffer, BJ ;
Gerhardt, GA .
NATURE, 1996, 380 (6571) :252-255
[6]  
Han SK, 1996, J NEUROCHEM, V66, P501
[7]  
Hou JGG, 1996, J NEUROCHEM, V66, P74
[8]  
Hou JGG, 1997, J NEUROCHEM, V69, P76
[9]   GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF [J].
Jing, SQ ;
Wen, DZ ;
Yu, YB ;
Holst, PL ;
Luo, Y ;
Fang, M ;
Tamir, R ;
Antonio, L ;
Hu, Z ;
Cupples, R ;
Louis, JC ;
Hu, S ;
Altrock, BW ;
Fox, GM .
CELL, 1996, 85 (07) :1113-1124
[10]  
Kearns CM, 1997, J NEUROSCI, V17, P7111